Bayer, Monsanto agree to $9 billion asset sale to win US clearance
German chemical and pharmaceutical company Bayer has agreed to sell approximately $9 billion in assets to address concerns the Department of Justice had with its proposed acquisition of US agricultural company...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content